VISICOL
LOE Approachingsodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate
NDAORALTABLET
Approved
Sep 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
VISICOL (sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate) by Bausch Health is clinical pharmacology phosphorus in the form of organic and inorganic phosphate has a variety of important biochemical functions in the body and is involved in many significant metabolic and enzyme reactions in almost all organs and tissues. First approved in 2000.
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VISICOL is an oral tablet containing sodium phosphate (dibasic anhydrous and monobasic monohydrate) used as a bowel cleansing agent prior to colonoscopy and other endoscopic procedures. It works by creating an osmotic effect in the gastrointestinal tract that promotes bowel evacuation. The drug replenishes phosphorus levels while facilitating intestinal cleansing through electrolyte-driven fluid shifts.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30%), signaling potential team restructuring and transition planning activities.
Mechanism of Action
CLINICAL PHARMACOLOGY Phosphorus in the form of organic and inorganic phosphate has a variety of important biochemical functions in the body and is involved in many significant metabolic and enzyme reactions in almost all organs and tissues. It exerts a modifying influence on the steady state of…
Worked on VISICOL at Bausch Health? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.